EE+ POEM Archive
Extended use of dabigatran no better than warfarin for high-risk pts after VTE; no net benefit vs placebo for avg-risk pts
Extended use of dabigatran no better than warfarin for high-risk pts after VTE; no net benefit vs placebo for avg-risk pts is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Extended Use of Dabigatran No Better Than Warfarin for High-risk Pts After VTE; No Net Benefit Vs Placebo for Avg-risk Pts." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427821/all/Extended_use_of_dabigatran_no_better_than_warfarin_for_high_risk_pts_after_VTE.
Extended use of dabigatran no better than warfarin for high-risk pts after VTE; no net benefit vs placebo for avg-risk pts. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427821/all/Extended_use_of_dabigatran_no_better_than_warfarin_for_high_risk_pts_after_VTE. Accessed March 24, 2023.
Extended use of dabigatran no better than warfarin for high-risk pts after VTE; no net benefit vs placebo for avg-risk pts. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427821/all/Extended_use_of_dabigatran_no_better_than_warfarin_for_high_risk_pts_after_VTE
Extended Use of Dabigatran No Better Than Warfarin for High-risk Pts After VTE; No Net Benefit Vs Placebo for Avg-risk Pts [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427821/all/Extended_use_of_dabigatran_no_better_than_warfarin_for_high_risk_pts_after_VTE.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Extended use of dabigatran no better than warfarin for high-risk pts after VTE; no net benefit vs placebo for avg-risk pts
ID - 427821
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427821/all/Extended_use_of_dabigatran_no_better_than_warfarin_for_high_risk_pts_after_VTE
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
